INTRODUCTION
Breast cancer is a common disease. Improved awareness in the general population of the role of genetic factors in the development of disease has resulted in increasing demands upon Genetic services, and consequently further burden on resources for mammographic screening. Inevitably, some of those women who receive breast screening because of their genetic risk will go on to develop breast cancer themselves. We looked at the population of women who had attended the Aberdeen Genetic Clinic because of their family history to determine those who subsequently developed disease.
METHOD
1837 women have been seen at the Aberdeen Genetic Clinic between January 1992 and January 1999, for assessment of their family histories of breast cancer. Risks for these individuals were estimated using Houlston data [1] to December 1997 and thereafter Claus data [2] . Of these, 583 women between the ages of 35 and 50 years, and 404 women over the age of 50 years received screening mammography because of their family history.
Extra mammographic surveillance was offered to those whose risk was estimated at more than twice the population average (i.e. greater than 16%). Those under 50 years of age were offered 2 yearly mammography from age 35 years. Those over 50 years of age were offered 18 monthly mammography to fit in with the NHS National Breast Screening Programme which offers 3 yearly mammography to all women between 50 and 64 years. Mammograms from both groups were assessed by the same team of radiologists.
Pathology registers were checked to ascertain those women who were at high genetic risk who had subsequently developed breast cancer. The expected rates of cancer for the two age groups were then estimated from Scottish cancer statistics [3] .
RESULTS
17 women who have attended the Aberdeen Genetic Clinic with a high-risk family history of breast or ovarian cancer have subsequently developed breast cancer. Of these, 6 were under the age of 50 years and 11 over 50 years (see Table 1 ). Amongst the younger group, 3 were detected as a result of an abnormal screening mammogram (one of which was a first screening event) and 3 were interval cancers (although one of these was detected at annual clinical examination). In the over 50 group, 9 were Short Communication Audit of Women Attending the Aberdeen Genetic Clinic with a Family History of Breast Cancer who Subsequently Develop Cancer detected as a result of an abnormal mammogram and only 2 were interval cancers. Three further individuals who had been seen at the Genetic Clinic because of their family history of breast cancer, but whose risk was estimated at below 16% prior to their diagnoses of breast cancer, were excluded from this study. Of these, two were under 50 years of age and the third was over 50 years. However, the diagnoses of breast cancer in these women have increased the risks of breast cancer for their first-degree relatives to above 16%. Expected rates of cancer (Cancer Registration Statistics, Scotland) over a period of 6 years for the respective screening groups would be 5.25 cancers in the under 50 group and 6.30 in the over 50's (see Table 2 ). Using the Chi-Squared test, the difference between observed and affected in the over 50 year group approached significance.
DISCUSSION
Screening mammography appears to be more effective in the older age group, probably reflecting the decreasing density of breast with age and also the aggressiveness of breast cancers in younger women. Risk analysis appears to be more helpful in predicting genetic cancers in this group, with nearly twice as many cancers occurring as expected from population risks.
However, analysis of risk in the under 50 years group did not help to detect more cancers than expected. This may be due to the availability of prophylactic mastectomy for women at high risk (i.e. women who have inherited or are at 50% risk of having inherited a breast cancer predisposing gene). To date, 8 women under 50 years of age have proceeded to prophylactic mastectomy in Aberdeen because of their risk, and therefore it is thought that their lifetime risk of developing breast cancer has been significantly reduced [4] . However, no women in the over 50 years group have yet opted for prophylactic mastectomy.
This data will be included in the European multicentre study to assess the outcomes of cancer detected in high-risk women who are receiving extra surveillance. Further assessment of the sensitivity and specificity of genetic risk assessment is required.
